Clinical Knowledge. Shared.

Clinical knowledge that moves practice forward.

Access relevant cases, guideline digests, evidence infographics and practice updates — curated for healthcare professionals and strengthened by peer contribution.

Verified HCP communityEditorially independentPublished after editorial review
Poll of the Week

Loading this week’s question…

The Platform

A trusted space where doctors learn, contribute and advance clinical practice.

MedScribe is a peer-led medical knowledge platform. Not another news portal, and not a repository of sponsored articles — a working library built with doctors, for doctors, where evidence and experience meet.

Every piece of content is organised by specialty, condition and format; labelled by provenance; and reviewed under a published editorial policy. Contribution is professional currency here — not popularity.

I

Knowledge Platform

Reliable, clinically relevant information organised by specialty, condition and content type — findable in seconds.

II

Clinical Learning Platform

Cases, polls and quizzes with answers and rationale turn passive reading into active learning.

III

Contribution Platform

Verified doctors publish clinical cases, guideline digests and clinical polls — with attribution.

IV

Collaboration Platform

Compliant, clearly disclosed opportunities for societies, hospitals, academic institutions and industry to support education.

How Verification Works

Verified doctors only, so you know who wrote what you read.

Verification help
  1. Create your account

    Your name, email and a password. Confirm your email with the 6-digit code we send you.

  2. Add your registration

    Your medical registration number and council, qualification and specialty. You can attach your registration certificate; it is stored privately.

  3. We check it

    Our team checks your details with the medical council. This usually takes a few working days, and we email you the moment it is decided.

  4. Full access

    Read complete cases and guideline digests in full, and contribute cases, guideline digests and polls under your own name.

Before verification, and as a visitor, you can read titles and short previews of cases and guideline digests. Registration is free.

Latest Clinical Case

GnRH Antagonist Therapy in Moderate-to-Severe Endometriosis: Clinical Efficacy of Elagolix

Patient

32-year-old · Female

Chief complaint

Full clinical details uploaded in attached case documents.

History

Attached clinical case documents submitted for editorial review.

Presentation

A 32-year-old nulliparous woman (BMI: 24.1 kg/m²) presented with a 7-year history of progressive dysmenorrhea, chronic pelvic pain, and dyspareunia after the failure of multiple hormonal therapies. Physical examination revealed bilateral…

Kamlesh Solaskar

Obstetrics & Gynaecology · Verified Clinical Center

Work through the case.

The full case has the work-up, the clinical questions and the discussion. Verified doctors can answer and see how their peers responded.

Read the case→
8 min

Guideline Update

What changed in the latest guideline?

Guidelines are lengthy, scattered and difficult to apply quickly. MedScribe distils each major update into what changed, why it matters, and what it means for your next clinic — with the original source one tap away.

No guideline digests published yet

Each digest shows the previous and the updated recommendation side by side, with why it matters and a link to the original source. They appear here once the editorial team publishes them.

Evidence in a Glance

Clinical cases and practice-changing evidence, drawn as infographics.

All infographics

Infographic · Obstetrics & Gynaecology

GnRH Antagonist Therapy in Moderate-to-Severe Endometriosis: Clinical Efficacy of Elagolix

32-year-old woman · Stage III endometriosis with severe dysmenorrhea · Elagolix 200mg twice daily with add-back therapy · 80% pelvic pain reduction at 6 months

Full infographic →

Contribute to MedScribe

Your experience can strengthen someone else’s practice.

Verified doctors publish with attribution, and each published case has a public page they can share. Every submission is checked by the editorial team before it goes live, and case authors confirm patient consent and anonymisation when they submit.

How it works — choose a type → submit → editorial review (three stages) → published with your name.

Clinical case study
Guideline digest
Clinical poll or quiz

Coming soon

Clinical image
Practice pearl
Review article
Expert commentary
Patient education material
Video
Podcast
Journal club topic

Editorial Governance

Every piece passes three stages before it reaches you.

1

Intake & Source Check

Each submission — from a verified doctor, our editors or an AI draft — is checked for completeness, patient anonymisation and the sources it relies on.

Editorial Team

2

Clinical & Evidence Review

A medical editor checks clinical accuracy against the cited evidence. AI drafts arrive with the sources they were written from, and the editor checks them before approving.

Medical Editor · AI-assisted checks

3

Compliance & Sign-off

Disclosures and sponsorship labels are confirmed, then the content is approved and published — or scheduled for publication — by a named editor.

Editorial Lead

AI assists the review — it never publishes. Every AI draft is checked and approved by a person before it goes live, and authors are told the outcome of every decision on their submission.

Societies & Institutions

Co-branded hubs that extend your educational reach.

Societies, hospitals and academic departments receive dedicated hubs — guidelines, consensus documents, meeting highlights, member resources and events — within MedScribe’s consistent editorial frame.

Guideline library

The society’s guidelines and consensus documents, summarised in MedScribe’s digest format

Meeting highlights

Key sessions and takeaways from annual meetings and conferences

Member resources

Practice protocols, case programmes and announcements for members

Events and webinars

Recorded sessions and upcoming events, listed alongside the hub

MedScribe by Medwiz Global

Two decades of evidence-led medical education stand behind this platform.

Medwiz Global has worked across therapy areas and borders since 2005 — with an evidence-first, compliant approach to medical communication. MedScribe is its long-term, owned digital home for clinical learning.

2005

Working since

10,000+

Projects delivered

20+

Therapy areas

10,000+

Experts engaged

100,000+

HCP engagements

Visit Medwiz Global →

Questions

Frequently asked questions

Help centre
Who can join MedScribe?
Doctors and other healthcare professionals with a medical registration. Anyone can read previews; full access and contributing are for professionals whose registration we have verified.
Is MedScribe free?
Yes. Registration and full access are free for verified doctors.
How long does verification take?
Usually a few working days. We check your registration with the medical council and email you as soon as a decision is made. See How verification works.
What can I see before I'm verified?
Titles and short previews of clinical cases and guideline digests. Verification opens them in full.
How is content checked?
Every item passes three editorial stages, and a person approves it before it is published. See the Editorial policy.
Does MedScribe use AI?
AI helps our editors draft and check, for example turning a submitted case document into our case layout. It never publishes anything or verifies anyone. See the AI use policy.
Do I get CME or CPD credit?
Not at present. MedScribe does not award accredited CME or CPD credit.
Can I contribute?
Yes, once verified: clinical cases, guideline digests and clinical polls, published under your name after editorial review.
How is my data protected?
We use only essential cookies, never sell your data, and keep verification documents in private storage. You can download your data or delete your account at any time. See Privacy & cookies.

Stay Informed

New cases and guideline updates, by email.

Occasional emails when new clinical cases, guideline digests and platform news are published. Unsubscribe any time.

We'll email you a link to confirm. See how we use your email.

Join the Community

Read. Reflect. Contribute.

Registration takes under two minutes. Verification unlocks full cases and guideline digests, contribution and your personalised specialty feed.